These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10077177)

  • 1. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study.
    Pezzotti P; Galai N; Vlahov D; Rezza G; Lyles CM; Astemborski J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):275-82. PubMed ID: 10077177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
    Prins M; Veugelers PJ
    AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.
    Rezza G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 17 Suppl 1():S13-6. PubMed ID: 9586645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
    Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
    AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
    Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
    BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
    Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
    AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
    Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
    AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.
    AIDS; 1992 Apr; 6(4):421-6. PubMed ID: 1616637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort].
    Pérez-Hoyos S; Aviñó M; Hernández I; González J; Ruiz I
    Gac Sanit; 1999; 13(5):337-45. PubMed ID: 10564846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
    Prins M; Hernández Aguado IH; Brettle RP; Robertson JR; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    AIDS; 1997 Nov; 11(14):1747-56. PubMed ID: 9386810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. Italian HIV Seroconversion Study (ISS).
    Dorrucci M; Balducci M; Pezzotti P; Sinicco A; Alberici F; Rezza G
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):65-70. PubMed ID: 10534148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion.
    Spijkerman IJ; Langendam MW; Veugelers PJ; van Ameijden EJ; Keet IP; Geskus RB; van den Hoek A; Coutinho RA
    Epidemiology; 1996 Nov; 7(6):571-7. PubMed ID: 8899381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
    Prins M; Brettle RP; Robertson JR; Hernández Aguado I; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    Int J Epidemiol; 1999 Jun; 28(3):541-9. PubMed ID: 10405862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group.
    Pezzotti P; Phillips AN; Dorrucci M; Lepri AC; Galai N; Vlahov D; Rezza G
    BMJ; 1996 Sep; 313(7057):583-6. PubMed ID: 8806246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.
    Hessol NA; Koblin BA; van Griensven GJ; Bacchetti P; Liu JY; Stevens CE; Coutinho RA; Buchbinder SP; Katz MH
    Am J Epidemiol; 1994 Jun; 139(11):1077-87. PubMed ID: 8192140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.
    Phillips AN; Pezzotti P; Lepri AC; Rezza G
    AIDS; 1994 Sep; 8(9):1299-305. PubMed ID: 7802984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis.
    Crum RM; Galai N; Cohn S; Celentano DD; Vlahov D
    Alcohol Clin Exp Res; 1996 Apr; 20(2):364-71. PubMed ID: 8730231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004.
    Grigoryan A; Hall HI; Durant T; Wei X
    PLoS One; 2009; 4(2):e4445. PubMed ID: 19214229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users.
    Galai N; Margolick JB; Astemborski J; Vlahov D
    Clin Immunol Immunopathol; 1996 May; 79(2):134-41. PubMed ID: 8620619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.